A new kind of cancer treatment works remarkably well for some patients but not others — and researchers want to know why
|12/17/2016||Posted by BusinessMediaguide.Com under General World News||
For some cancer patients, a new group of drugs has led to remarkable remissions with few side effects. But others have tried them, only to find little benefit and a lot of discomfort.
The treatment, broadly speaking, is called cancer immunotherapy. These drugs — many of which have become available in the past few years — have led to cautious optimism among oncologists who often had few options for treating certain cancers. Cancer researchers see promise. Drug companies see potential for a new group of mega moneymakers. Investors and billionaires, like former New York Mayor Michael Bloomberg and <a target="_blank" read more >>>